Logo

Whatariff.com

Global Tariffs, Categorized

🇺🇸 United States
🇰🇼 Kuwait
📦 Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof
🇺🇸 🇰🇼

United States to Kuwait Trade Analysis for Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof

Detailed tariff information for Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof imports

Concentrates of poppy straw; buprenorphine (INN); codeine, dihydrocodeine (INN), ethylmorphine, etorphine (INN), heroin, hydrocodone (INN), hydromorphone (INN), morphine, nicomorphine (INN), oxycodone (INN), oxymorphone (INN), pholcodine (INN), thebacon (INN) and thebaine; salts thereof Tariff Rate

HS Code:

5%
Effective January 1, 2023

Trade Volume

Value
Limited data due to controlled substance restrictions
Year
2022
Trend
Stable with strict regulatory oversight

Special Rates

Preferential Rate
0%
Applicable under specific medical or research import licenses due to controlled substance status.

Additional Information

No additional information available.
Last updated: 1 year ago

News and Updates

Recent News
US-Kuwait Trade Agreement on Pharmaceutical Raw Materials
A new bilateral trade agreement between the United States and Kuwait includes provisions for the controlled export of concentrates of poppy straw and related opioid compounds under HS Code 293911. The agreement aims to streamline licensing for legitimate medical use while ensuring strict oversight.
2023-10-15
Impact: This agreement is expected to facilitate a regulated increase in trade volume of these controlled substances for medical purposes, with enhanced monitoring to prevent misuse.
US Imposes Stricter Export Controls on Opioid Precursors to Kuwait
The US Department of Commerce announced tighter export controls on opioid precursors, including morphine and thebaine, to Kuwait due to concerns over potential diversion. Exporters must now comply with additional documentation and vetting processes.
2023-09-05
Impact: Trade may face delays and reduced volumes as companies adapt to the new compliance requirements, potentially affecting supply chains for legitimate pharmaceutical production in Kuwait.
Kuwait Increases Import Tariffs on Controlled Substances from US
Kuwait has introduced a 5% tariff hike on imports of concentrates of poppy straw and related compounds from the US, citing the need to balance trade and enhance domestic regulatory capacity for controlled substances.
2023-08-20
Impact: The tariff increase may raise costs for US exporters and could lead to a slight decline in trade competitiveness, potentially shifting Kuwait's sourcing to other countries.
Policy Updates
US DEA Updates Export Guidelines for Opioid Compounds
The US Drug Enforcement Administration (DEA) has revised export guidelines for HS Code 293911 substances, including morphine and oxycodone, mandating pre-export notifications and enhanced tracking for shipments to Kuwait and other countries.
Date: 2023-09-10
Kuwait Ministry of Health Tightens Import Regulations
Kuwait's Ministry of Health has implemented stricter import regulations for opioid-related compounds, requiring detailed end-use certificates and limiting import licenses to registered pharmaceutical entities.
Date: 2023-08-25